Schedule 13G/A
430 Schedule 13G/A filing by Morgan Stanley
Morgan Stanley reported beneficial ownership of 9 shares, representing 0% of TERNS PHARMACEUTICALS INC in this filing.
FiledJun 5, 2026
Ownership dateMay 31, 2026
Reported shares9
Reported ownership0%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
0
Shared voting power
0
Sole dispositive power
0
Shared dispositive power
0
Compared with the prior filing
How the reported position changed
This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for 430. A change between filings does not by itself establish when shares were bought or sold.
Previous filingMay 12, 2026
Reported share change-6,433,955
Ownership percentage change-5.6 pts
| Previous filing | This filing | |
|---|---|---|
| Reported shares | 6.4M | 9 |
| Reported ownership | 5.6% | 0% |
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Morgan Stanley
- CIK
- CIK0000895421
- Accession
- 0000895421-26-000192
- Form
- Schedule 13G/A
Read the filing in context